CVS Health Corporation(CVS)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
CVS | 121.18 B | 23.57x | 7.10% | 1.18% | $4.02 | 6.21% | 0.95x | 2.87% | $110.68 | $69.51 |
CI | 81.02 B | 11.99x | 6.70% | 2.27% | $25.58 | 16.76% | 0.74x | 2.05% | $304.44 | $234.20 |
LH | 26.21 B | 26.42x | 5.80% | 6.99% | $12.23 | 11.73% | 0.79x | 0.89% | $341.07 | $242.07 |
DGX | 26.17 B | 24.86x | 10.20% | 9.19% | $9.54 | 14.60% | 0.81x | 1.39% | $247.92 | $168.35 |
Peer Valuation & Performance Analysis
Peer group analysis for CVS Health Corporation (CVS) compared to its primary competitors (including CI, LH, DGX) reveals distinct metrics. CVS trades at a valuation premium compared to its competitors, with a P/E ratio of 23.6x versus the peer average of 21.1x (representing a 12% premium). This indicates that the market expects superior growth or commands a quality premium for CVS. In terms of growth, CVS's revenue growth of 7.1% is consistent with the peer average of 7.6%. Additionally, its net margin of 1.2% is below the peer average of 6.1%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• CVS ranks #2 in P/E ratio, #2 in revenue growth, and #4 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $93.25 | $94.91 | $93.20 | $94.75 | 7,066,075 | +2.23% |
| 2026-10-19 | $91.60 | $92.74 | $91.03 | $92.68 | 5,376,600 | +0.35% |
| 2026-10-16 | $93.24 | $93.35 | $92.05 | $92.36 | 6,980,700 | -0.24% |
| 2026-10-15 | $91.78 | $92.64 | $91.00 | $92.58 | 14,264,300 | +2.42% |
| 2026-10-14 | $88.10 | $90.78 | $88.10 | $90.39 | 9,331,700 | +3.24% |
| 2026-10-13 | $89.20 | $89.89 | $86.13 | $87.55 | 10,479,100 | -0.22% |
| 2026-10-12 | $86.60 | $87.98 | $86.05 | $87.74 | 11,574,200 | +1.83% |
| 2026-10-09 | $85.90 | $88.86 | $85.80 | $86.16 | 11,651,700 | -1.87% |
| 2026-10-08 | $87.86 | $88.50 | $86.82 | $87.80 | 7,833,900 | -0.17% |
| 2026-10-07 | $87.05 | $89.93 | $87.00 | $87.95 | 8,467,900 | +1.76% |
| 2026-10-06 | $86.80 | $87.08 | $85.53 | $86.43 | 11,038,700 | -0.67% |
| 2026-10-05 | $86.69 | $87.51 | $86.33 | $87.01 | 12,009,700 | +0.64% |
| 2026-10-02 | $85.25 | $87.15 | $85.25 | $86.46 | 10,463,000 | +1.48% |
| 2026-10-01 | $85.48 | $86.26 | $84.23 | $85.20 | 6,560,100 | -0.57% |
| 2026-09-30 | $87.04 | $87.44 | $85.42 | $85.69 | 8,379,100 | -1.62% |
Explore More Analysis for CVS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.